miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis
| Autor: | Alfred S. L. Cheng, Joanna H.M. Tong, Feng Wu, Jun Yu, Jinglin Zhang, Yuhang Zhou, Yi Pan, Yujuan Dong, Chi Chun Wong, Jesse Chung Sean Pang, Ka Fai To, Anthony W.H. Chan, Raymond W.M. Lung, Wei Kang, Shiyan Wang, Tingting Huang, Bin Zhang, Wing Po Chak, Weiqin Yang, Alvin Ho-Kwan Cheung |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
Cancer Research Carcinogenesis Muscle Proteins medicine.disease_cause 0302 clinical medicine RNA Small Interfering YAP1 Regulation of gene expression Gene knockdown Mice Inbred BALB C integumentary system lcsh:Cytology TEA Domain Transcription Factors DNA-Binding Proteins Gene Expression Regulation Neoplastic 030220 oncology & carcinogenesis Gene Knockdown Techniques Signal Transduction Immunology Down-Regulation Mice Nude Biology Protein Serine-Threonine Kinases Models Biological Article 03 medical and health sciences Cellular and Molecular Neuroscience Stomach Neoplasms Cell Line Tumor microRNA medicine Animals Humans Hippo Signaling Pathway lcsh:QH573-671 Adaptor Proteins Signal Transducing Hippo signaling pathway Base Sequence Connective Tissue Growth Factor YAP-Signaling Proteins Cell Biology Phosphoproteins CTGF MicroRNAs 030104 developmental biology Cancer research Ectopic expression Transcription Factors |
| Zdroj: | Cell Death & Disease Cell Death and Disease, Vol 9, Iss 2, Pp 1-16 (2018) |
| ISSN: | 2041-4889 |
| Popis: | miR-375 is a tumor-suppressive microRNA (miRNA) in gastric cancer (GC). However, its molecular mechanism remains unclear. The aim of this study is to comprehensively investigate how miR-375 is involved in Hippo pathway by targeting multiple oncogenes. miR-375 expression in gastric cancer cell lines and primary GC was investigated by qRT-PCR. The regulation of YAP1, TEAD4, and CTGF expression by miR-375 was evaluated by qRT-PCR, western blot, and luciferase reporter assays, respectively. The functional roles of the related genes were examined by siRNA-mediated knockdown or ectopic expression assays. The clinical significance and expression correlation analysis of miR-375, YAP1, and CTGF were performed in primary GCs. TCGA cohort was also used to analyze the expression correlation of YAP1, TEAD4, CTGF, and miR-375 in primary GCs. miR-375 was down-regulated in GC due to promoter methylation and histone deacetylation. miR-375 downregulation was associated with unfavorable outcome and lymph node metastasis. Ectopic expression of miR-375 inhibited tumor growth in vitro and in vivo. Three components of Hippo pathway, YAP1, TEAD4 and CTGF, were revealed to be direct targets of miR-375. The expression of three genes showed a negative correlation with miR-375 expression and YAP1 re-expression partly abolished the tumor-suppressive effect of miR-375. Furthermore, CTGF was confirmed to be the key downstream of Hippo-YAP1 cascade and its knockdown phenocopied siYAP1 or miR-375 overexpression. YAP1 nuclear accumulation was positively correlated with CTGF cytoplasmic expression in primary GC tissues. Verteporfin exerted an anti-oncogenic effect in GC cell lines by quenching CTGF expression through YAP1 degradation. In short, miR-375 was involved in the Hippo pathway by targeting YAP1-TEAD4-CTGF axis and enriched our knowledge on the miRNA dysregulation in gastric tumorigenesis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|